Gene · 38
NIH grants1,504
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,504
Download this page as JSON| Grant | Title | ACAT1 papers | Newest fiscal year |
|---|---|---|---|
| R01DK076077 | Adaptive and maladaptive repair after kidney injury | 1 | 2025 |
| R01DK093757 | Genetic epidemiology of rare and regulatory variants for metabolic traits | 1 | 2025 |
| R01DK104753 | Crosstalk Between Lipid Droplets and Other Organelles in Podocytes | 1 | 2025 |
| R01DK107667 | Selective mTORC1 inhibition to prevent and treat NAFLD and NASH | 1 | 2025 |
| R01DK112984 | Podocyte-Proximal Tubule Interactions in Diabetic Kidney Disease | 1 | 2025 |
| R01DK113103 | Metabolic Functions of Pyruvate Kinase M2 in Pancreatic Beta-cells | 1 | 2025 |
| R01DK114103 | Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance | 1 | 2025 |
| R01DK117850 | Systems Genetics Dissection of Non-alcoholic Steatohepatitis | 1 | 2025 |
| R01DK117965 | Regulation of Bile Acid Metabolism and Signaling in Metabolic Diseases | 1 | 2025 |
| R01DK124777 | Investigation into the function of RNA polymerase II promoter proximal pausing during terminal erythroid maturation | 1 | 2025 |
| R01DK127637 | Mitochondrial ADP privation: A unifying model for glucose-induced insulin secretion. | 1 | 2025 |
| R01DK129339 | The role of SerpinB2 in insulin resistance and inflammation | 1 | 2025 |
| R01DK130294 | Novel Biomarkers for Post-Liver Transplant NASH Fibrosis | 1 | 2025 |
| R01DK130342 | HDAC1 as a nutrient sensor in the development and progression of NAFLD | 1 | 2025 |
| R01EB024989 | Detection of Emergent Mechanical Properties of Biologically Complex Cellular States | 1 | 2025 |
| R01ES024745 | Mechanisms of pesticide-induced neuroinflammation and parkinsonism in aging mice. | 1 | 2025 |
| R01ES026033 | Organic-metal mixtures and neurodevelopment | 1 | 2025 |
| R01EY013178 | Novel Glaucoma Diagnostics for Structure and Function. | 1 | 2025 |
| R01EY018571 | Genetics of early onset retinal diseases | 1 | 2025 |
| R01EY022305 | NEIGHBORHOOD Consortium for POAG Genetics | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/grants?page=8